Reducing the burden of cardiovascular calcification in patients with chronic kidney disease

Journal of the American Society of Nephrology

Volumn 16, Issue 11 SUPPL. 2, 2005, Pages

  Qunibi, Wajeh Y ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMLODIPINE; ATORVASTATIN; BILE ACID SEQUESTRANT; CALCIMIMETIC AGENT; CALCIUM ACETATE; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; COLISTIMIDE; DIURETIC AGENT; ETIDRONIC ACID; FETUIN; GARLIC EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBANDRONIC ACID; NIFEDIPINE; OSTEOGENIC PROTEIN 1; OSTEOPROTEGERIN; PROTEIN FETUIN A; SEVELAMER; UNCLASSIFIED DRUG; VITAMIN D; CALCIUM; PHOSPHORUS;

ARTERY CALCIFICATION; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIALYSIS; DISEASE ASSOCIATION; HUMAN; HYPERCALCEMIA; HYPERLIPIDEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MINERAL METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; SECONDARY HYPERPARATHYROIDISM; BLOOD; CALCINOSIS; CHRONIC DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; KIDNEY DISEASE; PATHOPHYSIOLOGY;

CALCINOSIS; CALCIUM; CHRONIC DISEASE; CORONARY ARTERIOSCLEROSIS; HUMANS; KIDNEY DISEASES; PHOSPHORUS;

EID: 33644844933     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005060666     Document Type: Review

References (63)

1. Wexler L, Brundage B, Grouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K: Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation 94: 1175-1192, 1996
2. Wong ND, Vo A, Abrahamson D, Tobis JM, Eisenberg H, Detrano RC: Detection of coronary artery calcium by ultrafast computed tomography and its relation to clinical evidence of coronary artery disease. Am J Cardiol 73: 223-227, 1994
3. Rumberger JA, Brundage BH, Rader DJ, Kondos G: Electron beam computed tomographic coronary artery calcium scanning: A review and guidelines for use in asymptomatic persons. Mayo Clin Proc 74: 243-252, 1999
4. Wayhs R, Zelinger A, Raggi P: High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 39: 225-230, 2002
5. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27: 394-401, 1996
6. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000
7. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15: 1014-1021, 2000
8. Chertow GM, Burke SK, Raggi P; for the Treat to Goal Working Group: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62: 245-252, 2002
9. Qunibi WY, Nolan CR, Ayus JC: Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon. Kidney Int 82[Suppl]: 73-80, 2002
10. Qunibi WY: Consequences of hyperphosphatemia. Kidney Int 66[Suppl 90]: S8-S12, 2004
11. Moe SM: Calcific uremic arteriolopathy: A new look at an old disorder. NephSAP 3: 77-83, 2004
12. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H: Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17: 1713-1724, 2002
13. London GM, Guerin AP, Marchais AJ, Metivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18: 1731-1740, 2003
14. Lehto S, Niskanen L, Suhonen L, Ronnemaa T, Laakso M: Medial artery calcification. A neglected harbinger of cardiovascular complications in non insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16: 978-983, 1996
15. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM: Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39: 695-701, 2002
16. Block GA, Klassen PS, Lazarus ML, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004
17. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: e10-e17, 2000
18. Emmett M. A comparison of clinically useful phosphorus binders for patients with chronic kidney failure. Kidney Int 66 [Suppl 90]: S25-S32, 2004
19. Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, Pelham RW, Cleveland MV, Muenz LR, He DY, Nolan CR: Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study). Kidney Int 65: 1914-1926, 2004
20. Schmermund A, Baumgart D, Mohlenkamp S, Kriener P, Pump H, Gronemeyer D, Seibel R, Erbel R: Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: An electron-beam CT study. Arterioscler Thromb Vasc Biol 21: 421-426, 2001
21. Budoff MJ, Lane KL, Bakhsheshi H, Mao S, Grassmann BO, Friedman BC, Brundage BH: Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 86: 8-11, 2000
22. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ: Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339: 1972-1978, 1998
23. Achenbach S, Ropers D, Fohle K, Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, Bickel A, Haberl R, Steinbeck G, Moshage W, Daniel WG: Influence of lipid-lowering therapy on the progression of coronary artery calcification: A prospective evaluation. Circulation 106: 1077-1082, 2002
24. Nitta K, Akiba T, Nihei H: Colestimide co-administered with atorvastatin attenuates the progression of vascular calcification in hemodialysis patients. Nephrol Dial Transplant 19: 2156, 2004
25. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K: Significant association between the progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38: 64-69, 2001
26. Price PA, Buckley JR, Williamson MK: The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs, and kidneys in rats. J Nutr 131: 2910-2915, 2001
27. Mallick NP, Berlyne GM: Arterial calcification after vitamin-D therapy in hyperphosphatemic renal failure. Lancet 2: 1316-1320, 1968
28. Milliner DS, Zinsmeister AR, Leiberman E, Landing B: Soft tissue calcification in pediatric patients with end-stage renal disease. Kidney Int 38: 931-936, 1990
29. Merke J, Hofmann W, Goldschmidt D, Ritz E: Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 41: 112-114, 1987
30. Jono S, Nishizawa Y, Shioi A, Morii H: 1,25-dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98: 1302-1306, 1998
31. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350: 1516-1525, 2004
32. Shalhoub et al.: Calcitriol but not cinacalcet mediates calcification of bovine aortic SMC. J Am Soc Nephrol 15: 281A, 2004
33. Henley C, Colloton M, Cattley R, Shatzen E, Towler DA, Lacey D, Martin D: 1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) mediates aortic mineralization in a rat model of secondary hyperparathyroidism. Nephrol Dial Transplant 20: 1370-1377, 2005
34. Rodriguez et al.: Calcimimetic NPS R-568 decrease vascular calcification in 5/6 nephrectomized rats with SHPT treated with calcitriol. J Am Soc Nephrol 15: 279A, 2004
35. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW: Retardation of angiographic progression of coronary artery disease by nifedipine: Results of the International Nifedipine Trial on Atherosclerotic Therapy (INTACT). Lancet 335: 1109-1113, 1990
36. Waters D, Lesperance J, Fracetich M: A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 82: 1940-1953, 1990
37. Koshiyama H, Tanaka S, Minamikawa J: Effect of calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes. J Cardiovasc Pharmacol 33: 894-896, 1999
38. Motro M, Shemesh J: Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 37: 1410-1413, 2001
39. Wolfe RA, Ashby VP, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
40. Kendrick E: Cardiovascular disease and the renal transplant recipient. Am J Kidney Dis 38[Suppl 6]: S36-S43, 2001
41. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriolopathy in young adults with childhood-onset chronic renal failure. Circulation 106: 100-105, 2002
42. Moe SM, O'Neill KD, Reslerove M, Fineberg N, Persohn S, Meyer CA: Natural history of vascular calcification in dialysis and transplant patients. Nephrol Dial Transplant 19: 2387-2393, 2004
43. Stompor T, Pasowicz M, Sulowicz W, Dembinska-Kiec A, Tracz W: Trends in coronary artery calcification in peritoneal dialysis and transplant patients. Nephrol Dial Transplant 19: 3205-3206, 2004
44. Moe SM, O'Neill KD, Fineberg N, Persohn S, Ahmed S, Garrett P, Meyer CA: Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 18: 1152-1158, 2003
45. Hujairi NM, Afzali B, Goldsmith DJ: Cardiac calcification in renal patients: What we do and don't know. Am J Kidney Dis 43: 234-243, 2004
46. Moe SM, Reslerova M, Ketteler M, O'Neill K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX: Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67: 2295-2304, 2005
47. Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, Gladziwa U, Schurgers LJ, Vermeer C, Jahnen-Dechent W, Floege J: Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia. Kidney Int Suppl 84: S84-S87, 2003
48. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386: 78-81, 1997
49. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W: The calcium alpha2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112: 357-366, 2003
50. Price PA, Faus SA, Williamson MK: Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 20: 317-327, 2000
51. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H: Serum osteoprotegerin levels and the extent of vascular calcification in hemodialysis patients. Nephrol Dial Transplant 19: 1886-1889, 2004
52. Price AP, June HH, Buckley JR, Williansom MK: Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21: 1610-1616, 2001
53. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J: Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361: 827-833, 2003
54. Price PA, Faus SA, Williamson MK: The bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those which inhibit bone resorption. Arterioscler Thromb Vasc Biol 21: 817-824, 2001
55. Frye MA, Melton LJ, Beyant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, Riggs BL: Osteoporosis and calcification of the aorta. Bone Miner 19: 185-194, 1992
56. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW: Bone loss and the progression of abdominal aortic calcification over a 25 year period: The Framingham Heart Study. Calcif Tissue Int 68: 271-276, 2001;
57. erratum in Calcif Tissue Int 74: 208, 2004
58. Monney P, Nguyen Q-V, Perroud H, Descombes E: Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 19: 2130-2132, 2004
59. Kingma JGJ, Roy PE: Effect of 1-hydroxy-1,1-diphosphonate on arterial calcinosis induced by hypervitaminosis D: A morphologic investigation. J Exp Pathol 71: 145-153, 1990
60. Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H: Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44: 680-688, 2004
61. Budoff MJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH, Rosen RT, Amagase H: Inhibiting progression of coronary calcification using aged garlic extract in patients receiving statin therapy: A preliminary study. Prev Med 39: 985-991, 2004
62. Campbell JH, Efendy JL, Smith NJ, Campbell GR: Molecular basis by which garlic suppresses atherosclerosis. J Nutr 131: 1006S-1009S, 2001
63. Lange LA, Lange EM, Bielak LF, Langefeld CD, Kardia SL, Royston P, Turner ST, Sheedy II PF, Boerwinkle E, Peyser PA: Autosomal genome-wide scan for coronary artery calcification loci in sibships at high risk for hypertension. Arterioscler Thromb Vasc Biol 22: 418-423, 2002